Antinuclear Antibody Test Market Segmentation by Product (Assay, Reagent kits, and Software & Services); by Disease (Scleroderma, Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Others); by Technology (Immunofluorescence and Multiplex Assay, and ELISA); and by End-User (Hospitals, Clinical and Physician Laboratories, and Others) – Global Demand Analysis & Opportunity Outlook 2031